Seongnam-si, South Korea

Yong In Kim

USPTO Granted Patents = 6 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
6 patents (USPTO):

Title: The Innovative Contributions of Yong In Kim in Biomedicine

Introduction: Yong In Kim, an accomplished inventor based in Seongnam-si, South Korea, has made significant strides in the field of biomedicine. With a remarkable portfolio of 5 patents, Kim’s work focuses on innovative solutions to combat diseases related to angiogenesis and the angiogenesis-inducing factor Angiopoietin-2 (Ang2). His latest inventions highlight a commitment to advancing therapeutic approaches for various medical conditions.

Latest Patents: Among Kim's notable inventions is the patent titled "Humanized or affinity-matured anti Ang-2 antibody and uses thereof". This patent involves an anti-Ang2 antibody or an antigen-binding fragment that specifically targets Angiopoietin-2, featuring a complex interaction with the Tie2 receptor through Ang2. These innovations not only aim to deepen the understanding of angiogenesis but also offer new avenues for treatments. Another significant patent is "Angiopoietin-2 specific antibodies and uses thereof", which describes a method for inhibiting angiogenesis and treating diseases associated with Ang2's overproduction, alongside compositions for disease diagnosis.

Career Highlights: Yong In Kim currently works at Samsung Electronics Co., Ltd., a leading multinational company renowned for its commitment to technology and innovation. His position allows him to leverage his expertise in developing cutting-edge biomedical solutions. With a strong focus on research and development, Kim has positioned himself as a key player in advancing therapeutic antibody technology.

Collaborations: Throughout his career, Yong In Kim has collaborated with prominent professionals in the industry, including Seok Kyun Kim and Sang Yeul Han. These partnerships enhance the collaborative spirit of innovation and research, allowing for the cross-pollination of ideas that can lead to significant breakthroughs in biomedicine.

Conclusion: Yong In Kim's pioneering work and numerous patents underscore his vital role in advancing medical science and technology. His latest innovations, particularly in anti-Ang2 antibodies, have the potential to transform therapeutic applications. As he continues his journey at Samsung Electronics Co., Ltd., the contributions of this inventive leader will undoubtedly leave a lasting impact on the field of biomedicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…